Does Dr. OLUWAYEMISI ADEJUMO have financial conflicts of interest?

Dr. OLUWAYEMISI ADEJUMO (M.D.) has received a total of $1,827 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $1,827 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. OLUWAYEMISI ADEJUMO?

According to CMS Open Payments data, Dr. OLUWAYEMISI ADEJUMO received funding from W. L. GORE & ASSOCIATES ($380), ABBOTT LABORATORIES ($346), and NOVARTIS PHARMACEUTICALS CORPORATION ($338).

Does Dr. OLUWAYEMISI ADEJUMO receive research grants or speaking fees?

Dr. OLUWAYEMISI ADEJUMO has received $1,827 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. OLUWAYEMISI ADEJUMO

M.D.Real-Time Hydrated

Specialty: Internal Medicine, Interventional Cardiology

Practice Location: OAKLAND, CA 94602

NPI Number: 1699031179

LIFETIME INDUSTRY VALUE

$1,827

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ADEJUMO is a verified Internal Medicine, Interventional Cardiology practitioner based in OAKLAND, CA.

Between 2021 and 2024, Dr. ADEJUMO had an overall industry promotional and research financial footprint of $1,827 as recorded in the federal CMS Open Payments database.

$1,827 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ADEJUMO's primary funding source is W. L. GORE & ASSOCIATES, which accounts for $380 (representing 20.8% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

W. L. GORE & ASSOCIATES

Rank 1

$380

20.8%

ABBOTT LABORATORIES

Rank 2

$346

19%

NOVARTIS PHARMACEUTICALS CORPORATION

Rank 3

$338

18.5%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.